(VIANEWS) – RAMSAY GEN SANTE (GDS.PA), ELECT. MADAGASCAR (EEM.PA), DOCK.PETR.AMBES AM (DPAM.PA) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| RAMSAY GEN SANTE (GDS.PA) | 18.41% | 2023-11-10 09:21:42 |
| ELECT. MADAGASCAR (EEM.PA) | 15.75% | 2023-11-10 09:02:23 |
| DOCK.PETR.AMBES AM (DPAM.PA) | 8.41% | 2023-11-09 09:02:18 |
| TIETOEVRY (TIETO.OL) | 6.89% | 2023-11-10 08:43:50 |
| MERSEN (MRN.PA) | 3.91% | 2023-11-09 09:20:22 |
| VALNEVA (VLA.PA) | 3.35% | 2023-11-10 09:24:04 |
| MEDISTIM (MEDI.OL) | 2.08% | 2023-11-10 08:41:05 |
Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. RAMSAY GEN SANTE (GDS.PA)
18.41% Foward Dividend Yield
RAMSAY GEN SANTE’s last close was €20.40, 8.93% under its 52-week high of €22.40. Intraday change was -0.49%.
Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
Earnings Per Share
As for profitability, RAMSAY GEN SANTE has a trailing twelve months EPS of €0.45.
PE Ratio
RAMSAY GEN SANTE has a trailing twelve months price to earnings ratio of 45.56. Meaning, the purchaser of the share is investing €45.56 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.08%.
More news about RAMSAY GEN SANTE.
2. ELECT. MADAGASCAR (EEM.PA)
15.75% Foward Dividend Yield
ELECT. MADAGASCAR’s last close was €3.40, 17.07% under its 52-week high of €4.10. Intraday change was 0%.
Electricité et Eaux de Madagascar Société Anonyme engages in the luxury hotel business in Cambodia. It is also involved in the real estate, paper, and casino businesses. The company was formerly known as Viktoria Invest SA and changed its name to Electricité et Eaux de Madagascar Société Anonyme in January 2019. The company was founded in 1928 and is based in Paris, France.
Earnings Per Share
As for profitability, ELECT. MADAGASCAR has a trailing twelve months EPS of €-0.48.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ELECT. MADAGASCAR’s stock is considered to be oversold (<=20).
More news about ELECT. MADAGASCAR.
3. DOCK.PETR.AMBES AM (DPAM.PA)
8.41% Foward Dividend Yield
DOCK.PETR.AMBES AM’s last close was €460.00, 13.21% under its 52-week high of €530.00. Intraday change was 0.87%.
Les Docks des Pétroles d'Ambès -SA engages in the storage and shipping of petroleum products in France. It stores and distributes species, diesel, and combustibles, as well as bio, jet, technical, and marine fuel products. The company was founded in 1930 and is based in Carbon-Blanc, France.
Earnings Per Share
As for profitability, DOCK.PETR.AMBES AM has a trailing twelve months EPS of €49.45.
PE Ratio
DOCK.PETR.AMBES AM has a trailing twelve months price to earnings ratio of 9.38. Meaning, the purchaser of the share is investing €9.38 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.86%.
Yearly Top and Bottom Value
DOCK.PETR.AMBES AM’s stock is valued at €464.00 at 06:50 EST, way below its 52-week high of €530.00 and above its 52-week low of €450.00.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 21, 2023, the estimated forward annual dividend rate is 38 and the estimated forward annual dividend yield is 8.41%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 17.96M for the twelve trailing months.
More news about DOCK.PETR.AMBES AM.
4. TIETOEVRY (TIETO.OL)
6.89% Foward Dividend Yield
TIETOEVRY’s last close was kr236.80, 32.34% below its 52-week high of kr350.00. Intraday change was -2.31%.
TietoEVRY Oyj operates as a software and services company. It operates through six segments: Tietoevry Create, Tietoevry Banking, Tietoevry Care, Tietoevry Industry, Tietoevry Transform, and Tietoevry Connect. The Tietoevry Create segment provides digital agenda to create competitive products, as well as uses design, data, and cloud technologies for data-driven businesses. This segment also offers software and data engineering services. The Tietoevry Banking segment provides software products for digital transformation and financial institutions. The Tietoevry Care segment offers modular and interoperable software, reinventing Nordic health, and social care services. The Tietoevry Industry segment offers software and data solutions across various industries, such as public sector, pulp and paper, and utilities. The Tietoevry Transform segment provides enterprise-wide transformation across customers' business processes, applications and infrastructure. The Tietoevry Connect segment operates a cloud platform that provides a range of infrastructure choices ensuring security, resilience, and compliance for the customer's business. The company was formerly known as Tieto Oyj and changed its name to TietoEVRY Oyj in December 2019. TietoEVRY Oyj was founded in 1968 and is headquartered in Espoo, Finland.
Earnings Per Share
As for profitability, TIETOEVRY has a trailing twelve months EPS of kr19.39.
PE Ratio
TIETOEVRY has a trailing twelve months price to earnings ratio of 12.21. Meaning, the purchaser of the share is investing kr12.21 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.6%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
TIETOEVRY’s EBITDA is 535.04.
Volume
Today’s last reported volume for TIETOEVRY is 592 which is 90.65% below its average volume of 6335.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.9%, now sitting on 2.9B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 22, 2023, the estimated forward annual dividend rate is 16.64 and the estimated forward annual dividend yield is 6.89%.
More news about TIETOEVRY.
5. MERSEN (MRN.PA)
3.91% Foward Dividend Yield
MERSEN’s last close was €33.00, 28.18% under its 52-week high of €45.95. Intraday change was 1.69%.
Mersen S.A. manufactures and sells electrical power products and advanced materials in France, North America, rest of Europe, the Asia-Pacific, and internationally. It operates through two segments, Advanced Materials and Electrical Power. The company offers electrical protection and control products, such as IEC and UL/CSA low voltage general purpose fuses and fuse gears, high and medium voltage fuses, and power transfer solutions for rail vehicles, as well as surge protection, lightning protection, and power monitoring solutions; and power management solutions, including high speed fuses, DC protection for electric vehicles and battery, cooling solutions, bus bars, and aluminum electrolytic and film capacitors, as well as industrial motor maintenance and services. It also provides anticorrosion equipment comprising heat exchangers; columns, reactors, and pressure vessels; PTFE / PFA bellows, pipes, elbows, and fittings, as well as other equipment; graphite bursting discs; and corrosion resistant materials, as well as graphite specialties, such as isostatic graphite, carbon insulation, carbon/carbon composites, silicon carbide, and flexible graphite. In addition, the company offers carbon brushes, brush-holders, brush-rockers and brush gear housings, signal and power transmission systems, current collectors, wheel flange lubrication solutions, carbon dust collection systems, monitoring solutions, and slip and electrical ring assemblies, as well as cranes. It serves energy, electronics, transportation, corrosive chemicals, and process industries, as well as other markets comprising building and construction, elevators, elevators, defense, and outdoor LED lighting, as well as heating, ventilation, and air conditioning markets. The company was formerly known as Groupe Carbone Lorraine SA and changed its name to Mersen S.A. in 2010. Mersen S.A. was founded in 1889 and is headquartered in Courbevoie, France.
Earnings Per Share
As for profitability, MERSEN has a trailing twelve months EPS of €3.4.
PE Ratio
MERSEN has a trailing twelve months price to earnings ratio of 9.72. Meaning, the purchaser of the share is investing €9.72 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.21%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, MERSEN’s stock is considered to be oversold (<=20).
More news about MERSEN.
6. VALNEVA (VLA.PA)
3.35% Foward Dividend Yield
VALNEVA’s last close was €6.36, 18.98% below its 52-week high of €7.85. Intraday change was 7.33%.
Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and VLA2001, an inactivated whole-virus COVID-19 vaccine. The company also develops VLA15, a vaccine candidate, which is in Phase III clinical trial against Borrelia, the bacterium that causes Lyme disease; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; VLA1554, a vaccine candidate targeting human metapneumovirus; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of European countries, and internationally. Valneva SE has collaborations with Pfizer, Inc. to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. The company was founded in 1998 and is based in Saint-Herblain, France.
Earnings Per Share
As for profitability, VALNEVA has a trailing twelve months EPS of €0.09.
PE Ratio
VALNEVA has a trailing twelve months price to earnings ratio of 75.2. Meaning, the purchaser of the share is investing €75.2 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.81%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VALNEVA’s EBITDA is -49.11.
Yearly Top and Bottom Value
VALNEVA’s stock is valued at €6.77 at 06:50 EST, way under its 52-week high of €7.85 and way higher than its 52-week low of €3.95.
More news about VALNEVA.
7. MEDISTIM (MEDI.OL)
2.08% Foward Dividend Yield
MEDISTIM’s last close was kr192.00, 38.56% below its 52-week high of kr312.50. Intraday change was 2.56%.
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.42.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 31.15. Meaning, the purchaser of the share is investing kr31.15 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.37%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 11.9% and a drop 6.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 526.89M for the twelve trailing months.
More news about MEDISTIM.
